{"meshTagsMajor":["Mutation"],"meshTags":["Antineoplastic Agents","Benzenesulfonates","Exons","Gastrointestinal Neoplasms","Gastrointestinal Stromal Tumors","Humans","Mutation","Niacinamide","Phenylurea Compounds","Pyridines","Receptor, Platelet-Derived Growth Factor alpha"],"meshMinor":["Antineoplastic Agents","Benzenesulfonates","Exons","Gastrointestinal Neoplasms","Gastrointestinal Stromal Tumors","Humans","Niacinamide","Phenylurea Compounds","Pyridines","Receptor, Platelet-Derived Growth Factor alpha"],"publicationTypes":["Letter"],"title":"Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case series.","pubmedId":"22294526"}